Tarsus Pharmaceuticals, Inc.
TARS
51 insider filings · Latest: Sep 15, 2026
Common Stock Transactions
| Txn Date | Accepted | Insider | Type | Shares | Avg Price | Value | Shares Owned | Filing |
|---|---|---|---|---|---|---|---|---|
| Sep 15, 2026 | Sep 17 8:22 PM | Phd J Link WilliamDirector | Sale | 12,500 | $78.38 | $979.7K | 94,487(D) | View → |
| Sep 15, 2026 | Sep 15 8:51 PM | WILLIAM J LINK | Proposed Sale | 12,500 | $78.38 | $979.7K | — | View → |
| Sep 4, 2026 | Sep 9 8:14 PM | Bobak R. AzamianDirector, President/CEO and Board Chair | Sale | 10,000 | $90.56 | $905.6K | 827,991(I) | View → |
| Sep 4, 2026 | Sep 9 8:13 PM | Elizabeth Yeu LinChief Medical Officer | Sale | 13,953 | $87.50 | $1.2M | 1,590(I) | View → |
| Sep 4, 2026 | Sep 9 8:12 PM | Seshadri NeervannanChief Operating Officer | Sale | 4,564 | $85.00 | $387.9K | 78,532(D) | View → |
| Sep 4, 2026 | Sep 4 9:23 PM | BOBAK AZAMIAN | Proposed Sale | 10,000 | $90.56 | $905.6K | — | View → |
| Sep 4, 2026 | Sep 4 8:03 PM | Lin Elizabeth Yeu | Proposed Sale | 3,180 | $87.50 | $278.3K | — | View → |
| Sep 4, 2026 | Sep 4 7:59 PM | Lin Elizabeth Yeu | Proposed Sale | 10,773 | $87.50 | $942.6K | — | View → |
| Sep 4, 2026 | Sep 4 7:36 PM | Neervannan Seshadri | Proposed Sale | 4,564 | $85.00 | $387.9K | — | View → |
| Sep 2, 2026 | Sep 3 8:30 PM | Bobak R. AzamianDirector, President/CEO and Board Chair | Sale | 10,000 | $80.06 | $800.6K | 837,991(I) | View → |
| Sep 2, 2026 | Sep 3 8:29 PM | Elizabeth Yeu LinChief Medical Officer | Sale | 6,977 | $80.00 | $558.2K | 4,770(I) | View → |
| Sep 1, 2026 | Sep 3 8:29 PM | Elizabeth Yeu LinChief Medical Officer | Sale | 4,601 | $73.86 | $339.8K | 18,707(D) | View → |
| Sep 2, 2026 | Sep 2 8:31 PM | Lin Elizabeth Yeu | Proposed Sale | 1,590 | $80.00 | $127.2K | — | View → |
| Sep 2, 2026 | Sep 2 7:40 PM | Mottiwala Aziz | Proposed Sale | 8,000 | $81.80 | $654.4K | — | View → |
| Sep 2, 2026 | Sep 2 7:38 PM | Lin Elizabeth Yeu | Proposed Sale | 5,387 | $80.00 | $431.0K | — | View → |
| Sep 2, 2026 | Sep 2 6:39 PM | BOBAK AZAMIAN | Proposed Sale | 10,000 | $80.06 | $800.6K | — | View → |
| Sep 1, 2026 | Sep 1 8:09 PM | Mottiwala Aziz | Proposed Sale | 77,698 | $73.96 | $5.7M | — | View → |
| Sep 1, 2026 | Sep 1 6:23 PM | Lin Elizabeth Yeu | Proposed Sale | 4,601 | $73.86 | $339.8K | — | View → |
| Aug 25, 2026 | Aug 25 8:19 PM | Mottiwala Aziz | Proposed Sale | 81,332 | $71.85 | $5.8M | — | View → |
| Aug 19, 2026 | Aug 19 6:27 PM | Mottiwala Aziz | Proposed Sale | 53,043 | $72.00 | $3.8M | — | View → |
Page 1 of 6
Next →
Stock Options & Derivatives
| Txn Date | Accepted | Insider | Type | Shares | Exercise Price | Shares Owned | Filing |
|---|---|---|---|---|---|---|---|
| Mar 15, 2026 | Mar 17 8:35 PM | Seshadri NeervannanChief Operating Officer | Option Exercise | 26,287 | — | 15,067(D) | View → |
| Mar 15, 2026 | Mar 17 8:32 PM | Aziz MottiwalaChief Commercial Officer | Option Exercise | 26,482 | — | 16,574(D) | View → |
| Mar 15, 2026 | Mar 17 8:27 PM | Jeffrey S FarrowChief Financial Officer and Chief Strategy Officer | Option Exercise | 13,042 | — | 15,067(D) | View → |
| Mar 15, 2026 | Mar 17 8:24 PM | Bobak R. AzamianDirector, President/CEO and Board Chair | Option Exercise | 66,274 | — | 44,634(D) | View → |
| Mar 15, 2026 | Mar 17 8:20 PM | Elizabeth Yeu LinChief Medical Officer | Option Exercise | 2,511 | — | 7,534(D) | View → |
| Mar 5, 2026 | Mar 9 8:06 PM | Bryan WahlGeneral Counsel | Grant/Award | 44,471 | $74.90 | 17,161(D) | View → |
| Mar 5, 2026 | Mar 9 8:06 PM | Jeffrey S FarrowChief Financial Officer and Chief Strategy Officer | Grant/Award | 50,030 | $74.90 | 19,306(D) | View → |
| Mar 5, 2026 | Mar 9 8:06 PM | Aziz MottiwalaChief Commercial Officer | Grant/Award | 50,030 | $74.90 | 19,306(D) | View → |
| Mar 5, 2026 | Mar 9 8:06 PM | Seshadri NeervannanChief Operating Officer | Grant/Award | 44,471 | $74.90 | 17,161(D) | View → |
| Mar 5, 2026 | Mar 9 8:06 PM | Dianne C. WhitfieldChief Human Resources Officer | Grant/Award | 44,471 | $74.90 | 17,161(D) | View → |
| Mar 5, 2026 | Mar 9 8:06 PM | Elizabeth Yeu LinChief Medical Officer | Grant/Award | 44,471 | $74.90 | 17,161(D) | View → |
| Mar 5, 2026 | Mar 9 8:06 PM | Bobak R. AzamianDirector, President/CEO and Board Chair | Grant/Award | 157,499 | $74.90 | 60,776(D) | View → |
| Feb 18, 2026 | Feb 20 9:35 PM | I E Pyott DavidDirector | Grant/Award | 9,622 | $63.27 | 3,729(D) | View → |
← Previous
Page 2 of 2